EPIX ESSA Pharma
- 1.750
- 0.0000.00%
- 1.750
- 0.0000.00%
ESSA Pharma News
When Will ESSA Pharma Inc. (NASDAQ:EPIX) Turn A Profit?
ESSA Pharma's Cash Management: A Potential Risk to Shareholder Value and Market Stability
ESSA Pharma Inc. Reports Strategic Shift Amid Losses
ESSA Pharma: Fiscal Q4 Earnings Snapshot
ESSA Pharma Q4 2024 GAAP EPS $(0.14) Beats $(0.21) Estimate, Cash Balance Of $103.71M
ESSA Pharma | 8-K: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
Express News | ESSA Pharma Inc: Strategic Review Expected to Involve Headcount and Other Cost Reductions
Express News | ESSA Pharma Inc: Initiated Comprehensive Process to Explore and Review a Range of Strategic Options
ESSA Pharma | 10-K: FY2024 Annual Report
Express News | ESSA Pharma Inc: Qtrly Loss per Share $0.14
Express News | ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
Press Release: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024
Essa Pharma 4Q Loss/Shr 14c >EPIX
Bloom Burton Downgrades ESSA Pharma(EPIX.US) to Hold Rating, Cuts Target Price to $2.25
Express News | ESSA Pharma Inc - Terminates License Agreement With British Columbia Cancer Agency and Ubc
ESSA Pharma Introduces New Executive Severance Plan
Earnings Week Ahead: CRM, DOCU, OKTA, ZS, S, MRVL, LULU, DG, and More
Express News | Tang Capital Management, LLC Reports 9.7% Stake in ESSA Pharma as of Nov 1- SEC Filing
ESSA Pharma(EPIX.US) 10% Shareholder Sells US$12.02 Million in Common Stock
ESSA Pharma Slides As Insider Purchases Lose Another US$211k
No Data